Anavex Life Sciences Corp (AVXL)

[Doc328]

I am not a big fan of TA for Biotech stocks as SP is much more event driven. I find levels more meaningful than patterns in between important events. The 7.62 price has multiple touches and reversals over 18 months. SP hit that yesterday but could not break through. A convincing close above that level or several days above that level could be good for the price until the next event. I do find support/resistance levels to be useful for immediate price after a TLD release. Rett is late but the results will overwhelm any technical signal up or down. My prediction: 15 on meeting both endpoints with p<0.05 (24 if P <0.01 on both). 4.9 to 7.63 on nuanced data depending on how nuanced and 4 on a straight miss. And I rate the chances of he 3 scenarios as 20/60/20.